Advances in Prostate Cancer
(2018)
Advances in Prostate Cancer: pp.
-.
Chapter 5
Usefulness of combined androgen blockade therapy with gonadotropin-releasing hormone antagonist for bone metastatic prostate cancer with pretreatment prostate-specific antigen level ≥ 50 ng/mL